Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #11,021 to #11,070.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Neurotoxicity of MDMA controversy (1 revision)
  2. Neurotransmitter transporter (1 revision)
  3. Neurotrimin (1 revision)
  4. Neurotypical (1 revision)
  5. Neutraceutical (1 revision)
  6. Neutral cholesterol ester hydrolase 1 (1 revision)
  7. Neutral radiation astronomy (1 revision)
  8. Neutralisation (immunology) (1 revision)
  9. Neutrino radiation astronomy (1 revision)
  10. Neutron generator (1 revision)
  11. Neutron radiation (1 revision)
  12. Neutron radiation astronomy (1 revision)
  13. Neutron temperature (1 revision)
  14. Neutropenia case study one (1 revision)
  15. Neutropenia cost-effectiveness of therapy (1 revision)
  16. Neutropenia future or investigational therapies (1 revision)
  17. Neutrophil extracellular traps (1 revision)
  18. Neutrospec (1 revision)
  19. Nevirapine (patient information) (1 revision)
  20. Nevirapine clinical pharmacology (1 revision)
  21. Nevirapine clinical studies (1 revision)
  22. Nevirapine contraindications (1 revision)
  23. Nevirapine description (1 revision)
  24. Nevirapine dosage and administration (1 revision)
  25. Nevirapine drug interactions (1 revision)
  26. Nevirapine how supplied (1 revision)
  27. Nevirapine indications and usage (1 revision)
  28. Nevirapine labels and packages (1 revision)
  29. Nevirapine microbiology (1 revision)
  30. Nevirapine overdosage (1 revision)
  31. Nevirapine warnings and precautions (1 revision)
  32. New Code of NLP (1 revision)
  33. New England Journal of Medicine (1 revision)
  34. New Medical Center (1 revision)
  35. New drug application (1 revision)
  36. New formula for predicting long-term survival based on exercise treadmill testing (1 revision)
  37. Newpage (patient information) (1 revision)
  38. Newton (1 revision)
  39. Newton's laws of motion (1 revision)
  40. Niacin/Simvastatin (1 revision)
  41. Niacin/Simvastatin adverse reactions (1 revision)
  42. Niacin/Simvastatin clinical pharmacology (1 revision)
  43. Niacin/Simvastatin contraindications (1 revision)
  44. Niacin/Simvastatin description (1 revision)
  45. Niacin/Simvastatin dosage forms and strengths (1 revision)
  46. Niacin/Simvastatin drug interactions (1 revision)
  47. Niacin/Simvastatin indications and usage (1 revision)
  48. Niacin/Simvastatin labels and packages (1 revision)
  49. Niacin/Simvastatin nonclinical toxicology (1 revision)
  50. Niacin/Simvastatin overdosage (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:FewestRevisions"